Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor:-an in silico and in vitro approach.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Works matching IS 13570560 AND DT 2022 AND VI 39 AND IP 9
Results: 19
1
2
Correction to: Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
3
Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
4
NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives.
- Published in:
- 2022
- By:
- Publication type:
- journal article
5
Secretome of senescent hepatoma cells modulate immune cell fate by macrophage polarization and neutrophil extracellular traps formation.
- Published in:
- Medical Oncology, 2022, v. 39, n. 9, p. 1, doi. 10.1007/s12032-022-01732-w
- By:
- Publication type:
- Article
6
MORC2/β-catenin signaling axis promotes proliferation and migration of breast cancer cells.
- Published in:
- 2022
- By:
- Publication type:
- journal article
7
The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
8
Metformin inhibits the development and metastasis of colorectal cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
9
Questions to guide cancer evolution as a framework for furthering progress in cancer research and sustainable patient outcomes.
- Published in:
- 2022
- By:
- Publication type:
- journal article
10
Identification of prostate cancer subtypes based on immune signature scores in bulk and single-cell transcriptomes.
- Published in:
- 2022
- By:
- Publication type:
- journal article
11
Identification of oncogenic signaling pathways associated with the dimorphic metabolic dysregulations in gastric cancer subtypes.
- Published in:
- 2022
- By:
- Publication type:
- journal article
12
Inhibition of noncaspase proteases, calpain and proteasome, via ALLN and Bortezomib contributes to cell death through low degradation of pro-/anti-apoptotic proteins and apoptosis induction.
- Published in:
- 2022
- By:
- Publication type:
- journal article
13
E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2.
- Published in:
- 2022
- By:
- Publication type:
- journal article
14
Targeting UPR signaling pathway by dasatinib as a promising therapeutic approach in chronic myeloid leukemia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
15
Effects of folate-conjugated Fe<sub>2</sub>O<sub>3</sub>@Au core-shell nanoparticles on oxidative stress markers, DNA damage, and histopathological characteristics: evidence from in vitro and in vivo studies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
16
Cytoskeleton disruption by the metabolic inhibitor 3-bromopyruvate: implications in cancer therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
17
The crosstalk between long non-coding RNAs and the hedgehog signaling pathway in cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
18
Management of newly diagnosed glioblastoma multiforme: current state of the art and emerging therapeutic approaches.
- Published in:
- 2022
- By:
- Publication type:
- journal article
19
Integrated bioinformatics analysis to identify the key gene associated with metastatic clear cell renal cell carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article